DTC
ASMB icon

Deep Track Capital’s Assembly Biosciences ASMB Stock Holding History

Deep Track Capital’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-152,786
Closed -$2.38M – 59
2022
Q4 		$2.38M Sell
152,786
-97,214
-39% -$1.66M 0.1% 55
2022
Q3 		$4.92M Hold
250,000
– – 0.23% 61
2022
Q2 		$6.3M Hold
250,000
– – 0.41% 42
2022
Q1 		$6.18M Hold
250,000
– – 0.4% 42
2021
Q4 		$6.99M Buy
+250,000
New +$8.2M 0.49% 46

Other funds holding ASMB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Deep Track Capital's ASMB Position: Q1 2023 in Review

Deep Track Capital sold out of Assembly Biosciences (ASMB) in Q1 2023, closing a stake of 152,786 shares — an estimated $2.38M sold.

Deep Track Capital first reported a position in ASMB in Q4 2021 and held it in 5 quarters. The position peaked at $6.99M in Q4 2021. 37 funds tracked by Wall St. Rank hold ASMB as of Q1 2023.

  • Deep Track Capital reported no remaining Assembly Biosciences position as of Q1 2023 after selling out during the quarter.
  • Deep Track Capital sold 152,786 Assembly Biosciences shares in Q1 2023, an estimated $2.38M.
  • Deep Track Capital first reported a position in Assembly Biosciences in Q4 2021 and held it in 5 quarters.
  • Deep Track Capital's Assembly Biosciences position peaked at $6.99M in Q4 2021.
  • 37 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2023.

Based on Deep Track Capital's 13F filing for Q1 2023, filed 15 May 2023.